Camurus AB (publ) (CAMX.ST)

SEK 574.5

(1.77%)

Long Term Debt Summary of Camurus AB (publ)

  • Camurus AB (publ)'s latest annual long term debt in 2023 was 13.61 Million SEK , down -18.21% from previous year.
  • Camurus AB (publ)'s latest quarterly long term debt in 2024 Q2 was 10.59 Million SEK , down 0.0% from previous quarter.
  • Camurus AB (publ) reported annual long term debt of 16.64 Million SEK in 2022, down -12.06% from previous year.
  • Camurus AB (publ) reported annual long term debt of 18.92 Million SEK in 2021, down -7.17% from previous year.
  • Camurus AB (publ) reported quarterly long term debt of 10.59 Million SEK for 2024 Q2, down 0.0% from previous quarter.
  • Camurus AB (publ) reported quarterly long term debt of 14.83 Million SEK for 2023 Q3, down -9.69% from previous quarter.

Annual Long Term Debt Chart of Camurus AB (publ) (2023 - 2011)

Historical Annual Long Term Debt of Camurus AB (publ) (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 13.61 Million SEK -18.21%
2022 16.64 Million SEK -12.06%
2021 18.92 Million SEK -7.17%
2020 20.38 Million SEK -11.12%
2019 22.93 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%

Peer Long Term Debt Comparison of Camurus AB (publ)

Name Long Term Debt Long Term Debt Difference
Alligator Bioscience AB (publ) 7.51 Million SEK -81.12%
Ziccum AB (publ) 286 Thousand SEK -4659.79%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK -532.574%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -1501.529%
Genovis AB (publ.) 74.8 Million SEK 81.803%
Intervacc AB (publ) 142 Thousand SEK -9486.62%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK -353.767%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 58.219%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 79.133%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK -216.876%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -3110.613%
Egetis Therapeutics AB (publ) 103.4 Million SEK 86.835%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -1261.3%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 98.551%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 44.462%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 98.389%
Cyxone AB (publ) 74 Thousand SEK -18295.946%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -847.981%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 57.389%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -9909.559%
SynAct Pharma AB 58 Thousand SEK -23370.69%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -1501.529%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -673.027%
BioInvent International AB (publ) 14.53 Million SEK 6.343%
Alzinova AB (publ) 800 Thousand SEK -1601.625%
Oncopeptides AB (publ) 106.48 Million SEK 87.216%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 84.998%
Diamyd Medical AB (publ) 30.67 Million SEK 55.618%
Xbrane Biopharma AB (publ) 112.89 Million SEK 87.942%
Ascelia Pharma AB (publ) 176 Thousand SEK -7634.659%
Diagonal Bio AB (publ) - SEK -Infinity%